Autopsy report · NCT01987375

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

“logistics”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month before it started.
• Ran for about 1 year 5 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Eben Rosenthal

Sponsor type

University, hospital or other

Conditions

Head and Neck Cancer

Interventions

Cetuximab-IRDye800

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Inflammation in Type 2 Myocardial Infarction
  “Logistics and feasibility” (79% match in meaning)
• Alternatives to Hand Therapy for Hand Surgery Patients
  “Logistics (Research Staffing)” (74% match in meaning)
• miRNA and Myokines in Patients With PAH
  “Logistics related to research activity” (71% match in meaning)
• Glycemic Impact on Glioblastoma Outcomes
  “Logistical Issues” (64% match in meaning)
• Use of ICON™ to Detect Hemodynamic Variables During Dexmedetomidine Sedation in Children Undergoing Pulmonary Function Test
  “logistical challenges” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.